======= HMMR ======= == Gene Information == * **Official Symbol**: HMMR * **Official Name**: hyaluronan mediated motility receptor * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=3161|3161]] * **UniProt**: [[https://www.uniprot.org/uniprot/O75330|O75330]] * **Interactions**: [[https://thebiogrid.org/search.php?search=HMMR&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20HMMR|Open PubMed]] * **OMIM**: [[https://omim.org/entry/600936|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene is involved in cell motility. It is expressed in breast tissue and together with other proteins, it forms a complex with BRCA1 and BRCA2, thus is potentially associated with higher risk of breast cancer. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Dec 2008]. * **UniProt Summary**: Receptor for hyaluronic acid (HA) (By similarity). Involved in cell motility (By similarity). When hyaluronan binds to HMMR, the phosphorylation of a number of proteins, including PTK2/FAK1 occurs. May also be involved in cellular transformation and metastasis formation, and in regulating extracellular- regulated kinase (ERK) activity. May act as a regulator of adipogenisis (By similarity). {ECO:0000250|UniProtKB:Q00547}. No Pfam Domain information is available for this gene. |hyaluronan catabolic process| |hyaluronic acid binding| |hyaluronan metabolic process| |glycosaminoglycan catabolic process| |aminoglycan catabolic process| |mucopolysaccharide metabolic process| |microtubule cytoskeleton| |glycosaminoglycan metabolic process| |aminoglycan metabolic process| |carbohydrate derivative catabolic process| |regulation of G2/M transition of mitotic cell cycle| |regulation of cell cycle G2/M phase transition| |organic acid catabolic process| |carboxylic acid catabolic process| |regulation of mitotic cell cycle phase transition| |small molecule catabolic process| |regulation of cell cycle phase transition| |centrosome| |cell surface| |regulation of mitotic cell cycle| |regulation of cell cycle process| |carboxylic acid metabolic process| |oxoacid metabolic process| |organic acid metabolic process| |carbohydrate derivative metabolic process| |macromolecule catabolic process| |organonitrogen compound catabolic process| |regulation of cell cycle| |small molecule metabolic process| |organic substance catabolic process| |cellular catabolic process| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp231|Epothilone-B 0.0015μM R05 exp231]]|-2.49| |[[:results:exp103|Taxol 0.004μM R03 exp103]]|-2.48| |[[:results:exp217|Mdivi-1 15μM R05 exp217]]|-2.32| |[[:results:exp525|Sulforaphane 9μM R08 exp525]]|-1.85| |[[:results:exp190|Vincristine 0.0005μM R04 exp190]]|-1.83| |[[:results:exp312|2-Methoxyestradiol 0.55 to 1μM on day4 R07 exp312]]|-1.7| |[[:results:exp438|NN-Diethyl-meta-toluamide 500μM R08 exp438]]|1.71| |[[:results:exp475|CyclicAMP 200μM R08 exp475]]|1.95| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 17797 * **Expression level (log2 read counts)**: 6.45 {{:chemogenomics:nalm6 dist.png?nolink |}}